David G Nathan
Overview
Explore the profile of David G Nathan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fell G, Nathan D, Neuberg D
Blood Adv
. 2023 Apr;
7(14):3642-3643.
PMID: 37013955
No abstract available.
2.
3.
Ulirsch J, Verboon J, Kazerounian S, Guo M, Yuan D, Ludwig L, et al.
Am J Hum Genet
. 2019 Feb;
104(2):356.
PMID: 30735661
No abstract available.
4.
Ulirsch J, Verboon J, Kazerounian S, Guo M, Yuan D, Ludwig L, et al.
Am J Hum Genet
. 2018 Dec;
103(6):930-947.
PMID: 30503522
Diamond-Blackfan anemia (DBA) is a rare bone marrow failure disorder that affects 7 out of 1,000,000 live births and has been associated with mutations in components of the ribosome. In...
5.
Schoettler M, Nathan D
Hematol Oncol Clin North Am
. 2018 Jul;
32(4):581-594.
PMID: 30047412
Idiopathic acquired aplastic anemia is a rare, life-threatening bone marrow failure syndrome characterized by cytopenias and hypocellular bone marrow. The pathophysiology is unknown; the most favored model is of a...
6.
Field J, Majerus E, Gordeuk V, Gowhari M, Hoppe C, Heeney M, et al.
Blood Adv
. 2018 Jan;
1(20):1645-1649.
PMID: 29296811
Adenosine A receptor (AR) agonists have been shown to decrease tissue inflammation induced by hypoxia/reoxygenation in mice with sickle cell disease (SCD). The key mediator of the AR agonist's anti-inflammatory...
7.
8.
Nathan D
FASEB J
. 2017 Jul;
31(7):2722-2728.
PMID: 28663517
Here, I offer personal perspectives on cholesterol homeostasis that reflect my belief that certain aspects of the debate have been overstated.-Nathan, D. G. Cholesterol: the debate should be terminated.
9.
Ulirsch J, Lareau C, Ludwig L, Mohandas N, Nathan D, Sankaran V
Blood
. 2017 Jun;
130(9):1165-1168.
PMID: 28615220
No abstract available.
10.
Field J, Majerus E, Ataga K, Vichinsky E, Schaub R, Mashal R, et al.
PLoS One
. 2017 Feb;
12(2):e0171067.
PMID: 28152086
Trial Registration: clinicaltrials.gov NCT01783691.